Uptake and predictors of newborn respiratory syncytial virus (RSV) immunisation with nirsevimab in Ireland's national pilot programme: a cross-sectional study.

BMJ Open · 2026 · PMC13288963 · PMID 42331576

Europe PMC DOI

hedged sentence

0.0690

closest p · 1.4× alpha

0.0690

boldest claim

The sentences

did not reach statistical significancep=0.069so close (0.05 < p ≤ 0.1)

Uptake tended to be higher among infants admitted to the neonatal unit (aOR 1.56, 95% CI 0.99 to 2.47; p=0.056), indicating a consistent positive association that did not reach statistical significance and remained similar in the season-restricted model (aOR 1.53, 95% CI 0.97 to 2.41; p=0.069).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.